Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
> 26 27 26 27 O
= 27 28 27 28 O
1,000 29 34 29 34 B-lower_bound
/ 34 35 34 35 I-lower_bound
ul 35 37 35 37 I-lower_bound

Male 0 4 38 42 B-gender
subjects 5 13 43 51 I-gender
must 14 18 52 56 O
agree 19 24 57 62 B-contraception_consent
to 25 27 63 65 I-contraception_consent
use 28 31 66 69 I-contraception_consent
effective 32 41 70 79 I-contraception_consent
contraception 42 55 80 93 I-contraception_consent
or 56 58 94 96 I-contraception_consent
abstinence 59 69 97 107 I-contraception_consent
while 70 75 108 113 O
on 76 78 114 116 O
study 79 84 117 122 O
and 85 88 123 126 O
for 89 92 127 130 O
90 93 95 131 133 B-upper_bound
days 96 100 134 138 I-upper_bound
after 101 106 139 144 I-upper_bound
last 107 111 145 149 O
dose 112 116 150 154 O
of 117 119 155 157 O
study 120 125 158 163 O
drug 126 130 164 168 O

Patients 0 8 169 177 O
may 9 12 178 181 O
have 13 17 182 186 O
received 18 26 187 195 O
unlimited 27 36 196 205 O
lines 37 42 206 211 O
of 43 45 212 214 O
prior 46 51 215 220 O
therapy 52 59 221 228 B-treatment

Patients 0 8 229 237 O
who 9 12 238 241 O
are 13 16 242 245 O
randomized 17 27 246 256 O
to 28 30 257 259 O
the 31 34 260 263 O
control 35 42 264 271 O
arm 43 46 272 275 O
must 47 51 276 280 O
not 52 55 281 284 O
receive 56 63 285 292 O
therapy 64 71 293 300 B-treatment
based 72 77 301 306 O
on 78 80 307 309 O
prior 81 86 310 315 O
molecular 87 96 316 325 O
profiling 97 106 326 335 O

Patients 0 8 336 344 O
with 9 13 345 349 O
a 14 15 350 351 O
history 16 23 352 359 O
of 24 26 360 362 O
basal 27 32 363 368 B-cancer
cell 33 37 369 373 I-cancer
carcinoma 38 47 374 383 I-cancer
of 48 50 384 386 I-cancer
the 51 54 387 390 I-cancer
skin 55 59 391 395 I-cancer
or 60 62 396 398 O
pre 63 66 399 402 O
- 66 67 402 403 O
invasive 67 75 403 411 O
carcinoma 76 85 412 421 B-cancer
of 86 88 422 424 I-cancer
the 89 92 425 428 I-cancer
cervix 93 99 429 435 I-cancer

Patients 0 8 436 444 O
with 9 13 445 449 O
a 14 15 450 451 O
previous 16 24 452 460 O
malignancy 25 35 461 471 B-cancer
( 36 37 472 473 O
other 37 42 473 478 O
than 43 47 479 483 O
the 48 51 484 487 O
patients 52 60 488 496 O
' 60 61 496 497 O
known 62 67 498 503 O
cancer 68 74 504 510 B-cancer
) 74 75 510 511 O
that 76 80 512 516 O
were 81 85 517 521 O
treated 86 93 522 529 O
successfully 94 106 530 542 O
and 107 110 543 546 O
are 111 114 547 550 O
disease 115 122 551 558 O
- 122 123 558 559 O
free 123 127 559 563 O
for 128 131 564 567 O
at 132 134 568 570 O
least 135 140 571 576 O
3 141 142 577 578 B-lower_bound
years 143 148 579 584 I-lower_bound

Patients 0 8 585 593 O
with 9 13 594 598 O
metastatic 14 24 599 609 B-cancer
cancer 25 31 610 616 I-cancer

Platelets 0 9 617 626 B-clinical_variable
> 10 11 627 628 O
= 11 12 628 629 O
100,000 13 20 630 637 B-lower_bound
/ 20 21 637 638 I-lower_bound
ul 21 23 638 640 I-lower_bound
( 24 25 641 642 O
unless 25 31 642 648 O
these 32 37 649 654 O
abnormalities 38 51 655 668 O
are 52 55 669 672 O
due 56 59 673 676 O
to 60 62 677 679 O
bone 63 67 680 684 O
marrow 68 74 685 691 O
involvement 75 86 692 703 O
) 86 87 703 704 O

Serum 0 5 705 710 B-clinical_variable
creatinine 6 16 711 721 I-clinical_variable
clearance 17 26 722 731 I-clinical_variable
> 27 28 732 733 O
= 28 29 733 734 O
50 30 32 735 737 B-lower_bound
ml 33 35 738 740 I-lower_bound
/ 35 36 740 741 I-lower_bound
min 36 39 741 744 I-lower_bound
by 40 42 745 747 O
the 43 46 748 751 O
Cockcroft 47 56 752 761 O
- 56 57 761 762 O
Gault 57 62 762 767 O
formula 63 70 768 775 O

The 0 3 776 779 O
patient 4 11 780 787 O
has 12 15 788 791 O
Eastern 16 23 792 799 B-clinical_variable
Cooperative 24 35 800 811 I-clinical_variable
Oncology 36 44 812 820 I-clinical_variable
Group 45 50 821 826 I-clinical_variable
( 51 52 827 828 I-clinical_variable
ECOG 52 56 828 832 I-clinical_variable
) 56 57 832 833 I-clinical_variable
performance 58 69 834 845 I-clinical_variable
status 70 76 846 852 I-clinical_variable
0 77 78 853 854 B-lower_bound
- 78 79 854 855 O
1 79 80 855 856 B-upper_bound

The 0 3 857 860 O
patient 4 11 861 868 O
has 12 15 869 872 O
biopsy 16 22 873 879 B-treatment
- 22 23 879 880 O
accessible 23 33 880 890 O
tumor 34 39 891 896 B-cancer

The 0 3 897 900 O
patient 4 11 901 908 O
has 12 15 909 912 O
cardiac 16 23 913 920 O
conditions 24 34 921 931 O
as 35 37 932 934 O
follows 38 45 935 942 O
: 45 46 942 943 O
uncontrolled 47 59 944 956 O
hypertension 60 72 957 969 B-chronic_disease
( 73 74 970 971 O
blood 74 79 971 976 B-clinical_variable
pressure 80 88 977 985 I-clinical_variable
[ 89 90 986 987 I-clinical_variable
BP 90 92 987 989 I-clinical_variable
] 92 93 989 990 I-clinical_variable
> 94 95 991 992 O
160/100 96 103 993 1000 B-lower_bound
) 103 104 1000 1001 O
despite 105 112 1002 1009 O
optimal 113 120 1010 1017 B-treatment
therapy 121 128 1018 1025 I-treatment
, 128 129 1025 1026 O
uncontrolled 130 142 1027 1039 O
angina 143 149 1040 1046 B-chronic_disease
, 149 150 1046 1047 O
ventricular 151 162 1048 1059 B-chronic_disease
arrhythmias 163 174 1060 1071 I-chronic_disease
, 174 175 1071 1072 O
congestive 176 186 1073 1083 B-chronic_disease
heart 187 192 1084 1089 I-chronic_disease
failure 193 200 1090 1097 I-chronic_disease
( 201 202 1098 1099 O
New 202 205 1099 1102 B-clinical_variable
York 206 210 1103 1107 I-clinical_variable
Heart 211 216 1108 1113 I-clinical_variable
Association 217 228 1114 1125 I-clinical_variable
class 229 234 1126 1131 B-lower_bound
II 235 237 1132 1134 I-lower_bound
or 238 240 1135 1137 O
above 241 246 1138 1143 O
) 246 247 1143 1144 O

The 0 3 1145 1148 O
patient 4 11 1149 1156 O
has 12 15 1157 1160 O
concurrent 16 26 1161 1171 O
severe 27 33 1172 1178 O
and/or 34 40 1179 1185 O
uncontrolled 41 53 1186 1198 O
medical 54 61 1199 1206 B-chronic_disease
disease 62 69 1207 1214 I-chronic_disease
that 70 74 1215 1219 O
could 75 80 1220 1225 O
compromise 81 91 1226 1236 O
participation 92 105 1237 1250 O
in 106 108 1251 1253 O
the 109 112 1254 1257 O
study 113 118 1258 1263 O
( 119 120 1264 1265 O
i.e. 120 124 1265 1269 O
, 124 125 1269 1270 O
uncontrolled 126 138 1271 1283 O
diabetes 139 147 1284 1292 O
, 147 148 1292 1293 O
severe 149 155 1294 1300 O
infection 156 165 1301 1310 B-chronic_disease
requiring 166 175 1311 1320 O
active 176 182 1321 1327 B-treatment
treatment 183 192 1328 1337 I-treatment
, 192 193 1337 1338 I-treatment
severe 194 200 1339 1345 O
malnutrition 201 213 1346 1358 B-chronic_disease
, 213 214 1358 1359 O
chronic 215 222 1360 1367 O
severe 223 229 1368 1374 O
liver 230 235 1375 1380 B-chronic_disease
or 236 238 1381 1383 O
renal 239 244 1384 1389 B-chronic_disease
disease 245 252 1390 1397 I-chronic_disease
) 252 253 1397 1398 O

The 0 3 1399 1402 O
patient 4 11 1403 1410 O
has 12 15 1411 1414 O
peripheral 16 26 1415 1425 B-clinical_variable
neuropathy 27 37 1426 1436 I-clinical_variable
> 38 39 1437 1438 O
= 39 40 1438 1439 O
grade 41 46 1440 1445 B-lower_bound
2 47 48 1446 1447 I-lower_bound

The 0 3 1448 1451 O
patient 4 11 1452 1459 O
has 12 15 1460 1463 O
received 16 24 1464 1472 O
chemotherapy 25 37 1473 1485 B-treatment
, 37 38 1485 1486 O
surgery 39 46 1487 1494 B-treatment
, 46 47 1494 1495 O
or 48 50 1496 1498 O
radiotherapy 51 63 1499 1511 B-treatment
( 64 65 1512 1513 O
for 65 68 1513 1516 O
therapeutic 69 80 1517 1528 O
purposes 81 89 1529 1537 O
) 89 90 1537 1538 O
within 91 97 1539 1545 O
3 98 99 1546 1547 B-upper_bound
weeks 100 105 1548 1553 I-upper_bound
of 106 108 1554 1556 O
initiating 109 119 1557 1567 O
study 120 125 1568 1573 O
treatment 126 135 1574 1583 B-treatment
( 136 137 1584 1585 O
4 137 138 1585 1586 O
weeks 139 144 1587 1592 O
for 145 148 1593 1596 O
bevacizumab 149 160 1597 1608 B-treatment
or 161 163 1609 1611 O
investigational 164 179 1612 1627 B-treatment
drugs 180 185 1628 1633 I-treatment
) 185 186 1633 1634 O

The 0 3 1635 1638 O
patient 4 11 1639 1646 O
has 12 15 1647 1650 O
refractory 16 26 1651 1661 O
nausea 27 33 1662 1668 B-chronic_disease
and 34 37 1669 1672 O
vomiting 38 46 1673 1681 B-chronic_disease
or 47 49 1682 1684 O
chronic 50 57 1685 1692 O
gastrointestinal 58 74 1693 1709 B-chronic_disease
diseases 75 83 1710 1718 I-chronic_disease
( 84 85 1719 1720 O
e.g. 85 89 1720 1724 O
, 89 90 1724 1725 O
inflammatory 91 103 1726 1738 B-chronic_disease
bowel 104 109 1739 1744 I-chronic_disease
disease 110 117 1745 1752 I-chronic_disease
) 117 118 1752 1753 O

The 0 3 1754 1757 O
patient 4 11 1758 1765 O
is 12 14 1766 1768 O
unable 15 21 1769 1775 O
to 22 24 1776 1778 O
swallow 25 32 1779 1786 O
capsules 33 41 1787 1795 O
and/or 42 48 1796 1802 O
has 49 52 1803 1806 O
a 53 54 1807 1808 O
surgical 55 63 1809 1817 O
or 64 66 1818 1820 O
anatomical 67 77 1821 1831 O
condition 78 87 1832 1841 O
that 88 92 1842 1846 O
precludes 93 102 1847 1856 O
swallowing 103 113 1857 1867 O
and 114 117 1868 1871 O
absorbing 118 127 1872 1881 O
oral 128 132 1882 1886 B-treatment
medication 133 143 1887 1897 I-treatment
on 144 146 1898 1900 O
an 147 149 1901 1903 O
ongoing 150 157 1904 1911 O
basis 158 163 1912 1917 O
( 164 165 1918 1919 O
for 165 168 1919 1922 O
oral 169 173 1923 1927 B-treatment
therapy 174 181 1928 1935 I-treatment
only 182 186 1936 1940 O
) 186 187 1940 1941 O

Women 0 5 1942 1947 B-gender
of 6 8 1948 1950 O
childbearing 9 21 1951 1963 O
potential 22 31 1964 1973 O
must 32 36 1974 1978 O
agree 37 42 1979 1984 B-contraception_consent
to 43 45 1985 1987 I-contraception_consent
use 46 49 1988 1991 I-contraception_consent
adequate 50 58 1992 2000 I-contraception_consent
contraception 59 72 2001 2014 I-contraception_consent
( 73 74 2015 2016 O
hormonal 74 82 2016 2024 B-contraception_consent
or 83 85 2025 2027 O
barrier 86 93 2028 2035 B-contraception_consent
method 94 100 2036 2042 I-contraception_consent
of 101 103 2043 2045 I-contraception_consent
birth 104 109 2046 2051 I-contraception_consent
control 110 117 2052 2059 I-contraception_consent
; 117 118 2059 2060 O
abstinence 119 129 2061 2071 B-contraception_consent
) 129 130 2071 2072 O
prior 131 136 2073 2078 O
to 137 139 2079 2081 O
study 140 145 2082 2087 O
entry 146 151 2088 2093 O
and 152 155 2094 2097 O
for 156 159 2098 2101 O
the 160 163 2102 2105 O
duration 164 172 2106 2114 O
of 173 175 2115 2117 O
study 176 181 2118 2123 O
participation 182 195 2124 2137 O
; 195 196 2137 2138 O
childbearing 197 209 2139 2151 O
potential 210 219 2152 2161 O
will 220 224 2162 2166 O
be 225 227 2167 2169 O
defined 228 235 2170 2177 O
as 236 238 2178 2180 O
women 239 244 2181 2186 B-gender
who 245 248 2187 2190 O
have 249 253 2191 2195 O
had 254 257 2196 2199 O
menses 258 264 2200 2206 O
within 265 271 2207 2213 O
the 272 275 2214 2217 O
past 276 280 2218 2222 B-upper_bound
12 281 283 2223 2225 I-upper_bound
months 284 290 2226 2232 I-upper_bound
and 291 294 2233 2236 O
who 295 298 2237 2240 O
have 299 303 2241 2245 O
not 304 307 2246 2249 O
had 308 311 2250 2253 O
a 312 313 2254 2255 O
tubal 314 319 2256 2261 O
ligation 320 328 2262 2270 O
, 328 329 2270 2271 O
hysterectomy 330 342 2272 2284 B-treatment
, 342 343 2284 2285 O
or 344 346 2286 2288 O
bilateral 347 356 2289 2298 O
oophorectomy 357 369 2299 2311 B-treatment
; 369 370 2311 2312 O
should 371 377 2313 2319 O
a 378 379 2320 2321 O
woman 380 385 2322 2327 B-gender
become 386 392 2328 2334 O
pregnant 393 401 2335 2343 B-pregnancy
or 402 404 2344 2346 O
suspect 405 412 2347 2354 O
that 413 417 2355 2359 O
she 418 421 2360 2363 O
is 422 424 2364 2366 O
pregnant 425 433 2367 2375 O
while 434 439 2376 2381 O
participating 440 453 2382 2395 O
in 454 456 2396 2398 O
this 457 461 2399 2403 O
study 462 467 2404 2409 O
, 467 468 2409 2410 O
she 469 472 2411 2414 O
should 473 479 2415 2421 O
inform 480 486 2422 2428 O
her 487 490 2429 2432 O
treating 491 499 2433 2441 O
physician 500 509 2442 2451 O
immediately 510 521 2452 2463 O

atrial 0 6 2464 2470 B-chronic_disease
fibrillation 7 19 2471 2483 I-chronic_disease
with 20 24 2484 2488 O
heart 25 30 2489 2494 B-clinical_variable
rate 31 35 2495 2499 I-clinical_variable
> 36 37 2500 2501 O
100 38 41 2502 2505 B-lower_bound
beats 42 47 2506 2511 I-lower_bound
per 48 51 2512 2515 I-lower_bound
minute 52 58 2516 2522 I-lower_bound
( 59 60 2523 2524 I-lower_bound
bpm 60 63 2524 2527 I-lower_bound
) 63 64 2527 2528 I-lower_bound

baseline 0 8 2529 2537 B-clinical_variable
left 9 13 2538 2542 I-clinical_variable
ventricular 14 25 2543 2554 I-clinical_variable
ejection 26 34 2555 2563 I-clinical_variable
fraction 35 43 2564 2572 I-clinical_variable
( 44 45 2573 2574 I-clinical_variable
LVEF 45 49 2574 2578 I-clinical_variable
) 49 50 2578 2579 I-clinical_variable
= 51 52 2580 2581 O
< 52 53 2581 2582 O
50 54 56 2583 2585 B-upper_bound
% 56 57 2585 2586 I-upper_bound

has 0 3 2587 2590 O
had 4 7 2591 2594 O
significant 8 19 2595 2606 O
bowel 20 25 2607 2612 B-treatment
resection 26 35 2613 2622 I-treatment
that 36 40 2623 2627 O
would 41 46 2628 2633 O
preclude 47 55 2634 2642 O
adequate 56 64 2643 2651 O
absorption 65 75 2652 2662 O
( 76 77 2663 2664 O
for 77 80 2664 2667 O
oral 81 85 2668 2672 B-treatment
therapy 86 93 2673 2680 I-treatment
only 94 98 2681 2685 O
) 98 99 2685 2686 O

patients 0 8 2687 2695 O
have 9 13 2696 2700 O
declined 14 22 2701 2709 O
to 23 25 2710 2712 O
receive 26 33 2713 2720 O
standard 34 42 2721 2729 B-treatment
- 42 43 2729 2730 I-treatment
of 43 45 2730 2732 I-treatment
- 45 46 2732 2733 I-treatment
care 46 50 2733 2737 I-treatment
therapy 51 58 2738 2745 I-treatment

patients 0 8 2746 2754 O
who 9 12 2755 2758 O
had 13 16 2759 2762 O
no 17 19 2763 2765 O
prior 20 25 2766 2771 B-treatment
anticancer 26 36 2772 2782 I-treatment
therapy 37 44 2783 2790 I-treatment
and 45 48 2791 2794 O
had 49 52 2795 2798 O
surgical 53 61 2799 2807 B-treatment
resection 62 71 2808 2817 I-treatment
within 72 78 2818 2824 O
a 79 80 2825 2826 O
year 81 85 2827 2831 O
and 86 89 2832 2835 O
tumor 90 95 2836 2841 B-cancer
tissue 96 102 2842 2848 O
is 103 105 2849 2851 O
immediately 106 117 2852 2863 O
available 118 127 2864 2873 O
, 127 128 2873 2874 O
that 129 133 2875 2879 O
tumor 134 139 2880 2885 O
will 140 144 2886 2890 O
be 145 147 2891 2893 O
analyzed 148 156 2894 2902 O
and 157 160 2903 2906 O
no 161 163 2907 2909 O
biopsy 164 170 2910 2916 B-treatment
will 171 175 2917 2921 O
be 176 178 2922 2924 O
needed 179 185 2925 2931 O

patients 0 8 2932 2940 O
with 9 13 2941 2945 O
metastatic 14 24 2946 2956 B-chronic_disease
disease 25 32 2957 2964 I-chronic_disease
must 33 37 2965 2969 O
have 38 42 2970 2974 O
been 43 47 2975 2979 O
treated 48 55 2980 2987 O
with 56 60 2988 2992 O
established 61 72 2993 3004 O
standard 73 81 3005 3013 B-treatment
- 81 82 3013 3014 I-treatment
of 82 84 3014 3016 I-treatment
- 84 85 3016 3017 I-treatment
care 85 89 3017 3021 I-treatment
therapy 90 97 3022 3029 I-treatment

physicians 0 10 3030 3040 O
have 11 15 3041 3045 O
determined 16 26 3046 3056 O
that 27 31 3057 3061 O
such 32 36 3062 3066 O
established 37 48 3067 3078 O
therapy 49 56 3079 3086 B-treatment
is 57 59 3087 3089 O
not 60 63 3090 3093 O
sufficiently 64 76 3094 3106 O
efficacious 77 88 3107 3118 O

prior 0 5 3119 3124 O
or 6 8 3125 3127 O
current 9 16 3128 3135 O
cardiomyopathy 17 31 3136 3150 B-chronic_disease

unstable 0 8 3151 3159 O
ischemic 9 17 3160 3168 B-chronic_disease
heart 18 23 3169 3174 I-chronic_disease
disease 24 31 3175 3182 I-chronic_disease
( 32 33 3183 3184 O
myocardial 33 43 3184 3194 B-chronic_disease
infarction 44 54 3195 3205 I-chronic_disease
[ 55 56 3206 3207 I-chronic_disease
MI 56 58 3207 3209 I-chronic_disease
] 58 59 3209 3210 I-chronic_disease
within 60 66 3211 3217 O
6 67 68 3218 3219 B-upper_bound
months 69 75 3220 3226 I-upper_bound
prior 76 81 3227 3232 I-upper_bound
to 82 84 3233 3235 O
starting 85 93 3236 3244 O
treatment 94 103 3245 3254 B-treatment
or 104 106 3255 3257 O
angina 107 113 3258 3264 B-chronic_disease
requiring 114 123 3265 3274 O
use 124 127 3275 3278 O
of 128 130 3279 3281 O
nitrates 131 139 3282 3290 B-treatment
more 140 144 3291 3295 O
than 145 149 3296 3300 O
once 150 154 3301 3305 O
weekly 155 161 3306 3312 O
) 161 162 3312 3313 O

